...
首页> 外文期刊>International journal of gynecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics >Precancerous cervical lesions and HPV genotypes identified in previously unsatisfactory cervical smear tests after inexpensive glacial acetic acid processing
【24h】

Precancerous cervical lesions and HPV genotypes identified in previously unsatisfactory cervical smear tests after inexpensive glacial acetic acid processing

机译:在廉价的冰醋酸加工后以前不令人满意的宫颈涂抹试验中鉴定出癌前宫颈病变和HPV基因型

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objective To determine the effectiveness of using glacial acetic acid (GAA) to convert unsatisfactory bloody ThinPrep (TP) cervical smear test to satisfactory, and identify associated missed diagnoses and high‐risk HPV (hrHPV) genotypes. Methods In a retrospective descriptive cross‐sectional analysis, all TP tests performed in Mississippi, USA, 2012–2016, were evaluated for unsatisfactory results owing to blood. Tests that were converted to satisfactory by GAA treatment, and corresponding anomalies and HPV genotypes were identified. Results Among 106?384 TP tests, there were 1460 (1.37%) unsatisfactory results, of which 1442 (98.77%) were converted to satisfactory after GAA treatment. Laboratory preprocessing with GAA increased costs minimally. Precancerous lesions were detected in 166 (11.51%) of 1442 GAA‐treated samples, of which 12 (7.2%) were high‐grade lesions, 110 (66.3%) were atypical squamous cells of undetermined significance, and 63 (57.3%) tested positive for hrHPV. Of 60 genotyped samples, 39 (65%) had non‐HPV16 and non‐HPV18. Including mixed infections, 48 (80%) contained less‐common hrHPV types, reflecting an unexpected distribution in bloody specimens. Conclusions GAA pretreatment of bloody TP tests would reduce the incidence of unsatisfactory results and missed high‐grade lesions, and prevent the cost of repeat tests and delayed treatment. Clinicians without access to GAA should consider HPV?testing.
机译:摘要目的确定使用冰醋酸(Gaa)将不令人满意的血液薄雾(TP)宫颈涂抹试验造成令人满意的有效性,并鉴定相关的错过诊断和高风险HPV(HRHPV)基因型。方法在回顾性的描述性横截面分析中,在Mississippi,USA,2012-2016中进行的所有TP测试被评估为由于血液的不令人满意的结果。通过GAA治疗转化为令人满意的测试,并确定了相应的异常和HPV基因型。结果在106〜384 TP试验中,在GAA治疗后,有1460(1.37%)不令人满意的结果,其中1442(98.77%)转化为令人满意。实验室预处理GAA最低限度提高成本。在1666(11.51%)的1442个GaA处理样品中检测到癌前病变,其中12(7.2%)是高级病变,110例(66.3%)是非典型鳞状细胞,具有明显的显着意义,63(57.3%)测试HRHPV正面。在60个基因分型样品中,39(65%)具有非HPV16和非HPV18。包括混合感染,48(80%)含有较少常见的HRHPV类型,反映了血腥标本的意外分布。结论GAA预处理血腥TP检验将降低不令人满意的结果和错过高级病变的发病率,并防止重复试验和延迟治疗的成本。没有访问Gaa的临床医生应该考虑HPV?测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号